Washington Trust Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-64
Closed -$4.76K – 702
2025
Q2
$4.76K Buy
64
+12
+23% +$943 ﹤0.01% 576
2025
Q1
$4.61K Sell
52
-20
-28% -$1.89K ﹤0.01% 557
2024
Q4
$6.58K Buy
72
+3
+4% +$308 ﹤0.01% 532
2024
Q3
$7.71K Hold
69
– – ﹤0.01% 519
2024
Q2
$6.75K Buy
69
+10
+17% +$992 ﹤0.01% 522
2024
Q1
$5.95K Buy
59
+10
+20% +$879 ﹤0.01% 546
2023
Q4
$4.37K Buy
49
+13
+36% +$1.04K ﹤0.01% 583
2023
Q3
$2.75K Hold
36
– – ﹤0.01% 617
2023
Q2
$3.01K Buy
+36
New +$2.93K ﹤0.01% 601
2022
Q3
– Sell
-281
Closed -$25K – 910
2022
Q2
$25K Buy
281
+33
+13% +$3.42K ﹤0.01% 500
2022
Q1
$28K Sell
248
-38
-13% -$4.45K ﹤0.01% 540
2021
Q4
$35K Buy
+286
New +$31.8K ﹤0.01% 537

Other funds holding EMN

Washington Trust Advisors's EMN Position: Q3 2025 in Review

Washington Trust Advisors sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 64 shares — an estimated $4.76K sold.

Washington Trust Advisors first reported a position in EMN in Q4 2021 and held it in 12 quarters. The position peaked at $35K in Q4 2021. 664 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

  • Washington Trust Advisors reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 64 Eastman Chemical shares in Q3 2025, an estimated $4.76K.
  • Washington Trust Advisors first reported a position in Eastman Chemical in Q4 2021 and held it in 12 quarters.
  • Washington Trust Advisors's Eastman Chemical position peaked at $35K in Q4 2021.
  • 664 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Washington Trust Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.